Opinion

Resistance to last-line antibiotics

The increasing resistance to antibiotics and lack of antibiotics with new mechanisms of action against Gram-negative bacteria has caused the revival of old, formerly abandoned, drugs as last options.

News

Essential Diagnostics List (EDL) to be developed

Along with the recommendations on antibiotics, the WHO Expert Committee on the Selection of Essential Medicines urged that an Essential Diagnostics List (EDL) be developed.

News

Media workshop in Ecuador: a success

In the beginning of June, the International Media Training Workshop: Understanding Bacterial Resistance from Communication, was held in Cuenca, Ecuador.

News

ReAct withdraws from IMI project DRIVE-AB

After almost three years of participation in the research project DRIVE-AB, ReAct has decided to withdraw from the project. Read our full statement here.

News

Mother Earth, One Health – International Encounter in Argentina

On 12-16 June, together with partners and allies, ReAct Latin America is arranging a large conference in Rosario, Argentina titled Mother Nature, One Health. The conference boasts over 60 presenters and participants attending from more than 10 countries, many of which are from South America.

Opinion

Microbes – friend, foe or both?

Life on Earth is arranged in ecosystems where all species are dependent on each other in intricate networks. We humans are also part of ecosystems, but we also harbour one in ourselves, an ecosystem of microbes called the human microbiome.

It is time to stop thinking about bacteria only as something bad that need to be exterminated and start thinking about ecology. We also need to develop new anti-infective therapies that do not also kill our microbiome when they kill the pathogenic microbes that make us sick.

News

New Factsheet from ReAct: The Human Microbiome

To learn more about our microbiome, read the new ReAct factsheet on the topic: “All You Wanted to Know About Microbes But Were Afraid to Ask… The Human Microbiome”.

News

Key take-aways from the World Health Assembly 2017 on antimicrobial resistance

During the 70th World Health assembly 60 countries and 11 non-state actors took the floor in what ended up being a 3-hour long debate on antimicrobial resistance. The debate touched on progress in developing national action plans and challenges in their implementation; support and concerns over the joint WHO, OIE and FAO progress document on the Development and Stewardship Framework as well as the newly established ad-hoc UN Inter-Agency Coordination Group.

News

Successful antimicrobial resistance media training in Kenya

Beginning of May, ReAct and EPN in partnership with the AMR Media Network Kenya conducted a one-day media training on antimicrobial resistance. The purpose was to raise awareness among journalists on antimicrobial resistance as a major public health challenge. The day was hosted by the Kenya Medical Research Institute (KEMRI).

News

ReAct Asia Pacific hosts workshop on antimicrobial resistance in the farm sector

Beginning of May, ReAct Asia Pacific organized a one-day consultation entitled “Workshop on Anti-Microbial Resistance and use of Antibiotics in non-human sectors” at Thiruvananthapuram, the capital city of the State of Kerala, India. The workshop attracted over 60 delegates.

News

ReAct supports countries in the development of National Action Plans on AMR

National Action Plans are an essential component of the global strategies to address antibiotic resistance. At the country level, ReAct supports the development of National Action Plans together with partners from WHO, FAO, OIE and civil society organizations.

Opinion

National action plans and global AMR framework on the agenda as 70th World Health Assembly

Antimicrobial resistance features on the agenda at the 70th World Health Assembly. Focus will be on country progress in developing their National Action Plans on antimicrobial resistance, progress on finalizing the Global Development and Stewardship Framework and finally the setup of the ad hoc UN Interagency Coordination Group.

News

ReAct co-hosts side event during World Health Assembly

Monday 22nd May, during the 70th World Health Assembly, ReAct, members of the Antibiotic Resistance Coalition and allies including South Centre, Médecins Sans Frontières, Drugs for Neglected Diseases Initiative, Health Action International and Medicus Mundi International will be co-hosting a side event.

World Water Day

Hand hygiene saves lives

The most influential measure to prevent infections in all of recorded history has been hand hygiene. As such, hand hygiene is not only about preventing infections, but also controlling antibiotic resistance. Hand hygiene is the single most important – and most cost-effective – measure to control spread of pathogens whether resistant to antibiotics or not.

World water day

Hand hygiene to prevent infections

Hand hygiene is the single most effective measure to stop transmission of health care associated pathogens. A variety of basic actions can be used to prevent and control infections.

A selection of basic hand hygiene resources can be found in the ReAct Toolbox.

Opinion

Lack of access to old antibiotics drives antibiotic resistance development and impairs patient outcomes

Old, but still effective antibiotics used to treat a variety of common bacterial infections are becoming more difficult to access in many countries – often because companies withdraw the drugs from the market for commercial reasons.

News

Free online course: Antibiotic Resistance: the Silent Tsunami

The free online course “Antibiotic Resistance: the Silent Tsunami” introduces the concepts of antibiotic resistance and what actions are needed to meet this global health threat. Sign up now, start 24 April.

Opinion

New antibiotics in the news

Every now and then, news headlines report on findings of new antibiotics, such as “Maple Syrup Can Kill Superbugs”. Often they are portrayed as ”new”, ”potent”, ”killing superbugs” or having ”no resistance development”. Just reading the headlines, you would be forgiven for thinking the antibiotic crisis is close to being solved. But this is not the case.

News

Tell Our Bac-Stories!

In one way or another we are all storytellers, we all have something to say. This is why ReAct Latin America, in cooperation with the University of Azuay and the Catholic University of Cuenca, has launched a regional open call: Tell Our Bac-Stories! The purpose is to collect stories about antibiotic resistance, Sumak Kawsay (an indigenous term for well being), antibiotic misuse, nutrition, mother earth, one health and similar topics.

News

Presentation of the Alforja Validation Project

A few weeks ago, the Alforja Validation Project was presented to the students of the Medicin Faculty from the Universidad Del Azuay and the Universidad Católica de Cuenca. This event took place in the Administration Room of the Universidad del Azuay, which was entirely filled with lots of enthusiastic guests.

News

Professor Otto Cars to serve as Expert in UN Inter-Agency Coordination Group on Antimicrobial Resistance

This week Professor Otto Cars, founder of ReAct – Action on Antibiotic Resistance, was formally nominated to the United Nations (UN) ad-hoc Interagency Coordination Group on Antimicrobial Resistance (ICG-AMR) by the United Nations Secretary General.

Opinion

India’s link between tuberculosis and antibiotic resistance

Improving detection, diagnosis, and treatment of tuberculosis in India, home to the world’s largest number of tuberculosis patients, may hold the key to bringing down both antimicrobial and antibiotic resistance globally.

News

India’s new National Action Plan on Antimicrobial Resistance

As one of the countries most affected by antimicrobial resistance India is now taking rapid strides to address the growing problem.

Opinion

Professor Larsson on emissions from antibiotics production and India’s National Action Plan on AMR

Professor Joakim Larsson welcomes the section focusing on emissions from antibiotics production in new India’s draft for National Action Plan on Antibiotic Resistance.

Opinion

Environmental effects of antibiotics in sewage

Clean, fresh water is one of the most important natural resources of the world. Yet large amounts of chemicals, including antibiotics, are released into the environment through wastewater.

Opinion

Boston Consulting Group report shies away from addressing affordable access and stewardship

In a follow-up to a previous report, the Boston Consulting Group (BCG) last week released Breaking through the Wall: A Call for Concerted Action on Antibiotics Research and Development, for the German Federal Ministry of Health.

Opinion

WHO Releases Priority Pathogens List

ReAct welcomes the published WHO priority pathogens list (PPL), which is the first global effort to guide and promote research and development (R&D) of new antibiotics.  The major objective of the PPL is to guide the prioritization of incentives and funding, help align R&D priorities with public health needs and support global coordination in the fight against antibiotic-resistant bacteria.

Opinion

Could the use of Antimicrobial Peptides create resistance to ourselves?

In the wake of antimicrobial resistance and the severe lack of new antibiotics being discovered, researchers have turned to alternative strategies.

News

Antibiotic Smart Use project nominated for global UN Award

In a major recognition of its contributions to public health Thailand’s Antibiotic Smart Use (ASU) project has been nominated for the prestigious UN Public Service Award 2017.

News

Recap of WHO 140th Executive Board meeting

The discussions on antimicrobial resistance (AMR) at the World Health Organization’s (WHO’s) 140th Executive Board meeting, had several interesting interventions from Member States on the key areas that the WHO was given responsibility over in the UNGA Political Declaration on AMR from September 2016.

News

New collaboration on strategies for tackling antibiotic resistance

ReAct and Stockholm Resilience Centre join forces on the global antibiotic resistance challenge.

Opinion

ReAct briefings for the 140th WHO Executive Board

For the 140th session of WHO Executive Board, which run from January 23 to February 1, ReAct has developed and shared a briefing document for the agenda point on Antimicrobial Resistance (AMR ) and a number of other relevant agenda points for Member State Missions in Geneva to consider.

News

The role of faith-based organizations in taking action against antibiotic resistance

Late December 2016 a group of more than 30 experts from the faith based health sector was invited to attend a workshop on strengthening faith-based engagement in “Combating the Emergence and Spread of Antimicrobial Resistance”, at the Vatican.

Opinion

Bacteriophages as a part of hospital hygiene

Health-care associated infections are troublesome from many aspects, not only are they often more virulent or more resistant but also strike at the heart of health care: people go to the hospital to be cured, only to contract another potentially lethal disease.

Opinion

ReAct wishes for 2017!

ReAct wishes for 2017, node by node.

Opinion

Consensus around delinkage emerges - of sorts

A literature review on proposed incentive mechanisms for the R&D of new antibiotics by the EU-US TATFAR has shown a broad consensus on recommending delinkage. However, differences in definition are hiding underneath the consensus.

Opinion

Bottlenecks of antibiotic research need to be addressed

While problems with antibiotic discovery and development are often discussed in the context of funding and return on investment, these factors are not the only ones. Even if the financial bottlenecks would be resolved, significant scientific and structural problems are still present and need to be addressed. We highlight a few of the scientific bottlenecks in antibiotic discovery, with links to further reading.